WHO ICTRP trial
Study of Brentuximab Vedotin in Children and Adolescents With Relapsed or…
EUCTR2011-001240-29-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-001240-29-GB |
|---|---|
| Public title | Study of Brentuximab Vedotin in Children and Adolescents With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma |
| Scientific title | A Phase 1/2 Study of Brentuximab Vedotin (SGN-35) in Pediatric Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma |
| Primary sponsor | Millennium Pharmaceuticals, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;United States;Mexico;Spain;Netherlands;Germany;Italy;United Kingdom |
| Conditions | Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma MedDRA version: 19.1 Level: LLT Classification code 10020328 Term: Hodgkin's lymphoma System Organ Class: 100000004864 MedDRA version: 19.1 Level: LLT… |
| Interventions | Trade Name: Adcetris®, Product Name: Adcetris® Product Code: SGN-35 Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: Brentuximab vedotin CAS Number: 914088-09-8 Current Sponsor code: SGN-35… |
| Registration date | Sep 28, 2011 |
| Target size | 42 |
| Secondary IDs | C25002;2011-001240-29-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: